BaroPace Announces RelieveHFpEF-II, Its Phase I First-in-Human Trial of PressurePace™, Its Patent-Pending Pacemaker Control Algorithm for the Treatment of Heart Failure with Preserved Ejection Fractio

Press Release BaroPace Inc. announces its Phase I first-in-human trial of PressurePaceTM, its patent-pending pacemaker control algorithm for the treatment of heart failure with preserved ejection fraction (HFpEF), met both its primary endpoints of qu

A PHP Error was encountered

Severity: Notice

Message: Trying to get property of non-object

Filename: frontend/page.content.php

Line Number: 69

Backtrace:

File: /var/www/html/america.easybranches.com/application/views/frontend/page.content.php
Line: 69
Function: _error_handler

File: /var/www/html/america.easybranches.com/application/controllers/Page_content.php
Line: 45
Function: view

File: /var/www/html/america.easybranches.com/application/controllers/Page_content.php
Line: 9
Function: content

File: /var/www/html/america.easybranches.com/index.php
Line: 330
Function: require_once

Jun 19 2024
43
4702 Views

BaroPace Announces RelieveHFpEF-II, Its Phase I First-in-Human Trial of PressurePace™, Its Patent-Pending Pacemaker Control Algorithm for the Treatment of Heart Failure with Preserved Ejection Fractio — BaroPace Announces RelieveHFpE

ISSAQUAH, Wash.–(BUSINESS WIRE)–June 18, 2024– BaroPace Inc. announces its Phase I first-in-human trial of PressurePaceTM, its patent-pending pacemaker control algorithm for the treatment of heart failure with preserved ejection fraction (HFpEF), met... [3786 chars]